Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Live attenuated vaccines for pandemic influenza.

Chen GL, Subbarao K.

Curr Top Microbiol Immunol. 2009;333:109-32. doi: 10.1007/978-3-540-92165-3_5. Review.

PMID:
19768402
2.

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

Ambrose CS, Luke C, Coelingh K.

Influenza Other Respir Viruses. 2008 Nov;2(6):193-202. doi: 10.1111/j.1750-2659.2008.00056.x. Review.

3.

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.

Pitisuttithum P, Boonnak K, Chamnanchanunt S, Puthavathana P, Luvira V, Lerdsamran H, Kaewkungwal J, Lawpoolsri S, Thanachartwet V, Silachamroon U, Masamae W, Schuetz A, Wirachwong P, Thirapakpoomanunt S, Rudenko L, Sparrow E, Friede M, Kieny MP.

Lancet Infect Dis. 2017 Aug;17(8):833-842. doi: 10.1016/S1473-3099(17)30240-2. Epub 2017 May 19.

4.

Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.

Choi EH, Song MS, Park SJ, Pascua PN, Baek YH, Kwon HI, Kim EH, Kim S, Jang HK, Poo H, Kim CJ, Choi YK.

Arch Virol. 2015 Jul;160(7):1729-40. doi: 10.1007/s00705-015-2442-y. Epub 2015 May 12.

PMID:
25959557
5.

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.

Rudenko L, Naykhin A, Donina S, Korenkov D, Petukhova G, Isakova-Sivak I, Losev I, Stukova M, Erofeeva M, Nikiforova A, Power M, Flores J.

Hum Vaccin Immunother. 2015;11(12):2839-48. doi: 10.1080/21645515.2015.1069931.

6.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
7.

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).

Rudenko L, Desheva J, Korovkin S, Mironov A, Rekstin A, Grigorieva E, Donina S, Gambaryan A, Katlinsky A.

Influenza Other Respir Viruses. 2008 Nov;2(6):203-9. doi: 10.1111/j.1750-2659.2008.00064.x.

8.

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

Kiseleva I, Dubrovina I, Fedorova E, Larionova N, Isakova-Sivak I, Bazhenova E, Pisareva M, Kuznetsova V, Flores J, Rudenko L.

Vaccine. 2015 Dec 8;33(49):7008-14. doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.

PMID:
26432909
9.

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Jadhao SJ, Achenbach J, Swayne DE, Donis R, Cox N, Matsuoka Y.

Vaccine. 2008 Mar 25;26(14):1742-50. doi: 10.1016/j.vaccine.2008.01.036. Epub 2008 Feb 13.

PMID:
18336962
10.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiń≠ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
11.

Influenza viruses with rearranged genomes as live-attenuated vaccines.

Pena L, Sutton T, Chockalingam A, Kumar S, Angel M, Shao H, Chen H, Li W, Perez DR.

J Virol. 2013 May;87(9):5118-27. doi: 10.1128/JVI.02490-12. Epub 2013 Feb 28.

12.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

13.

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21.

14.

Development of vaccine strains of H5 and H7 influenza viruses.

Soda K, Sakoda Y, Isoda N, Kajihara M, Haraguchi Y, Shibuya H, Yoshida H, Sasaki T, Sakamoto R, Saijo K, Hagiwara J, Kida H.

Jpn J Vet Res. 2008 Jan;55(2-3):93-8.

PMID:
18318111
15.

Designing vaccines for pandemic influenza.

Horimoto T, Kawaoka Y.

Curr Top Microbiol Immunol. 2009;333:165-76. doi: 10.1007/978-3-540-92165-3_8. Review.

PMID:
19768405
16.

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.

Rudenko L, Isakova-Sivak I.

Expert Rev Vaccines. 2015 Mar;14(3):395-412. doi: 10.1586/14760584.2015.979159. Epub 2015 Jan 2. Review.

PMID:
25555687
17.

Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.

Chen Z, Baz M, Lu J, Paskel M, Santos C, Subbarao K, Jin H, Matsuoka Y.

J Virol. 2014 Jun;88(12):7016-23. doi: 10.1128/JVI.00100-14. Epub 2014 Apr 9.

18.

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.

Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K.

Vaccine. 2014 Nov 28;32(50):6798-804. doi: 10.1016/j.vaccine.2014.09.070. Epub 2014 Oct 16.

PMID:
25446831
19.

Safety and immunogenicity of Sinovac's prototype pandemic influenza H5N1 vaccines: a review on clinical trials.

Qiu YZ, Yin WD.

Influenza Other Respir Viruses. 2008 Nov;2(6):237-42. doi: 10.1111/j.1750-2659.2008.00067.x. Review.

20.

Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.

Jang YH, Byun YH, Lee YJ, Lee YH, Lee KH, Seong BL.

J Virol. 2012 May;86(10):5953-8. doi: 10.1128/JVI.07149-11. Epub 2012 Mar 21.

Supplemental Content

Support Center